HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

High-Level Expression of Alkaline Phosphatase by Adeno-Associated Virus Vector Ameliorates Pathological Bone Structure in a Hypophosphatasia Mouse Model.

Abstract
Hypophosphatasia (HPP) is a systemic skeletal disease caused by mutations in the gene encoding tissue-nonspecific alkaline phosphatase (TNALP). We recently reported that survival of HPP model mice can be prolonged using an adeno-associated virus (AAV) vector expressing bone-targeted TNALP with deca-aspartate at the C terminus (TNALP-D10); however, abnormal bone structure and hypomineralization remained in the treated mice. Here, to develop a more effective and clinically applicable approach, we assessed whether transfection with TNALP-D10 expressing virus vector at a higher dose than previously used would ameliorate bone structure defects. We constructed a self-complementary AAV8 vector expressing TNALP driven by the chicken beta-actin (CBA) promoter (scAAV8-CB-TNALP-D10). The vector was injected into both quadriceps femoris muscles of newborn HPP mice at a dose of 4.5 × 1012 vector genome (v.g.)/body, resulting in 20 U/mL of serum ALP activity. The 4.5 × 1012 v.g./body-treated HPP mice grew normally and displayed improved bone structure at the knee joints in X-ray images. Micro-CT analysis showed normal trabecular bone structure and mineralization. The mechanical properties of the femur were also recovered. Histological analysis of the femurs demonstrated that ALP replacement levels were sufficient to promote normal, growth plate cartilage arrangement. These results suggest that AAV vector-mediated high-dose TNALP-D10 therapy is a promising option for improving the quality of life (QOL) of patients with the infantile form of HPP.
AuthorsAki Nakamura-Takahashi, Toshiki Tanase, Satoru Matsunaga, Seikou Shintani, Shinichi Abe, Yuko Nitahara-Kasahara, Atsushi Watanabe, Yukihiko Hirai, Takashi Okada, Akira Yamaguchi, Masataka Kasahara
JournalCalcified tissue international (Calcif Tissue Int) Vol. 106 Issue 6 Pg. 665-677 (06 2020) ISSN: 1432-0827 [Electronic] United States
PMID32076747 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • ALPL protein, mouse
  • Alkaline Phosphatase
Topics
  • Alkaline Phosphatase (genetics)
  • Animals
  • Cancellous Bone (pathology)
  • Dependovirus
  • Disease Models, Animal
  • Genetic Therapy
  • Genetic Vectors
  • Hypophosphatasia (therapy)
  • Mice
  • Quality of Life

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: